The Academies have provided leadership in the past on controversial new areas of genetic research, such as recombinant DNA technology, human embryonic stem cell research, human cloning, and “gain-of-function” research. In keeping with these past efforts, the National Academy of Sciences and the National Academy of Medicine have launched a new initiative to inform decision making related to recent advances in human gene-editing research. [Learn about related Academies’ studies and reports on genetic research]
The initiative includes an international summit to convene global experts to discuss the scientific, ethical, and governance issues associated with human gene-editing research, as well as a comprehensive study by a multidisciplinary, international committee that will examine the scientific underpinnings and clinical, ethical, legal, and social implications of human gene editing. The committee will issue a report in 2016 with findings and recommendations for the responsible use of human gene-editing research.
Upcoming Public Meeting in Paris
The consensus committee will host a public meeting in Paris on April 29 focusing on the principles underlying human gene editing governance and policy. This event will be held one day after a workshop on the current scientific activities and regulatory landscape for human gene editing in the European Union, organized by the Federation of European Academies of Medicine. Watch a live webcast of the public meeting on April 29
Slides and Videos from the February Meeting
On Feb. 11, the NAS/NAM Human Gene Editing consensus committee heard input from select stakeholder groups, including public engagement experts, affected communities, industry, regulatory bodies, and members of the public who came to share their perspectives. Presentation slides and recorded videos of the talks and discussions are now available online.
Summary of International Summit Now Available
A Meeting in Brief is now available that summarizes the December International Summit on Human Gene editing.